We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+13.06%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$4.23B
AUM Growth
+$208M
Cap. Flow
+$191M
Cap. Flow %
4.51%
Top 10 Hldgs %
66.8%
Holding
503
New
83
Increased
81
Reduced
97
Closed
181

Top Buys

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$383M
2
DFS
Discover Financial Services
DFS
+$224M
3
BECN
Beacon Roofing Supply, Inc.
BECN
+$183M
4
WBA
Walgreens Boots Alliance
WBA
+$110M
5
JWN
Nordstrom
JWN
+$95.8M

Top Sells

Rank Stock Value
1
HCP
HashiCorp, Inc. Class A Common Stock
HCP
+$235M
2
SMAR
Smartsheet Inc.
SMAR
+$216M
3
EDR
Endeavor Group Holdings, Inc.
EDR
+$144M
4
SUM
Summit Materials, Inc. Class A Common Stock
SUM
+$103M
5
ALTR
Altair Engineering Inc
ALTR
+$97.9M

Sector Composition

Rank Sector Weight
1 Energy 17.21%
2 Healthcare 16.93%
3 Financials 12.93%
4 Industrials 12.5%
5 Technology 10.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XLI icon
226
PUT
State Street Industrial Select Sector SPDR ETF
XLI
$33.6B
$361K 0.01%
+113,500
New +$15.3M
SPY icon
227
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$818B
$346K 0.01%
85,000
-45,000
-35% -$26.4M
XBI icon
228
PUT
State Street SPDR S&P Biotech ETF
XBI
$10.1B
$329K 0.01%
200,000
+150,000
+300% +$13.4M
GRAB icon
229
Grab
GRAB
$15B
$318K 0.01%
+70,291
New +$328K
SWTX
230
PUT
DELISTED
SpringWorks Therapeutics
SWTX
$315K 0.01%
+45,000
New +$2.07M
SABR icon
231
PUT
Sabre
SABR
$886M
$303K 0.01%
688,600
– –
LVS icon
232
PUT
Las Vegas Sands
LVS
$29.9B
$287K 0.01%
37,200
– –
TRML
233
DELISTED
Tourmaline Bio
TRML
$272K 0.01%
+17,860
New +$286K
NCLH icon
234
PUT
Norwegian Cruise Line
NCLH
$8.89B
$267K 0.01%
188,800
-45,000
-19% -$1.08M
ORIC icon
235
Oric Pharmaceuticals
ORIC
$1.34B
$266K 0.01%
47,642
-127,204
-73% -$1.11M
LION icon
236
Lionsgate Studios
LION
$3.85B
$261K 0.01%
35,000
-95,774
-73% -$748K
CGEM icon
237
Cullinan Oncology
CGEM
$1.16B
$249K 0.01%
32,903
-23,192
-41% -$223K
DYN icon
238
Dyne Therapeutics
DYN
$4.83B
$224K 0.01%
21,422
+8,838
+70% +$126K
DRUG
239
Bright Minds Biosciences
DRUG
$793M
$215K 0.01%
+5,963
New +$218K
EH
240
EHang Holdings
EH
$404M
$209K ﹤0.01%
+10,000
New +$203K
ARQT icon
241
Arcutis Biotherapeutics
ARQT
$3.32B
$206K ﹤0.01%
13,201
-64,354
-83% -$907K
CATX icon
242
Perspective Therapeutics
CATX
$339M
$205K ﹤0.01%
96,060
-27,183
-22% -$81.6K
ABBV icon
243
AbbVie
ABBV
$431B
$204K ﹤0.01%
973
-6,515
-87% -$1.27M
SLN
244
Silence Therapeutics
SLN
$554M
$177K ﹤0.01%
62,639
-66,351
-51% -$324K
IWM icon
245
PUT
iShares Russell 2000 ETF
IWM
$82.1B
$172K ﹤0.01%
45,000
+9,000
+25% +$1.95M
EWTX icon
246
PUT
Edgewise Therapeutics
EWTX
$4.78B
$169K ﹤0.01%
+45,000
New +$1.18M
XIFR
247
PUT
XPLR Infrastructure LP
XIFR
$1.08B
$165K ﹤0.01%
20,600
-6,500
-24% -$73.7K
STWD icon
248
PUT
Starwood Property Trust
STWD
$5.9B
$160K ﹤0.01%
172,500
+34,400
+25% +$676K
CNTB
249
Connect Biopharma Holdings
CNTB
$138M
$148K ﹤0.01%
268,946
-241,755
-47% -$224K
OMF icon
250
PUT
OneMain Financial
OMF
$7.48B
$135K ﹤0.01%
34,400
+3,900
+13% +$207K
8 9
10
11 12

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
SAG
SageView Advisory Group Newport Beach, California $2.96B AUM 15.81% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return

UBS O'Connor's Q1 2025 Portfolio in Review

As of Q1 2025, UBS O'Connor held 503 positions worth $4.23B, up 5.2% from $4.02B the previous quarter. Its ten largest holdings account for 67% of the portfolio.

UBS O'Connor deployed $191M of net new capital in Q1 2025, opening 83 new positions and adding to 81 existing holdings. Its largest new stake was Beacon Roofing Supply, Inc.: 1,575,016 shares worth $195M.

By sector, the portfolio is most concentrated in Energy at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Juniper Networks, an estimated $71.4M trimmed.

  • UBS O'Connor's largest Q1 2025 buy was Beacon Roofing Supply, Inc.: 1,575,016 shares worth $195M.
  • UBS O'Connor added most to Intra-Cellular Therapies Inc. in Q1 2025, an estimated $383M increase.
  • UBS O'Connor's biggest Q1 2025 reduction was Juniper Networks, cutting an estimated $71.4M.
  • UBS O'Connor fully exited HashiCorp, Inc. Class A Common Stock in Q1 2025, selling an estimated $235M.
  • UBS O'Connor's ten largest holdings make up 67% of its $4.23B portfolio in Q1 2025.
  • UBS O'Connor opened 83 new positions and closed 181 in Q1 2025.
  • UBS O'Connor's portfolio value rose 5.2% quarter-over-quarter to $4.23B.

Based on UBS O'Connor's 13F filing for Q1 2025, filed 15 May 2025.